SUB1 and lung adenocarcinoma: To further validate whether SOX9 is a downstream factor of PC4 in mediating lung adenocarcinoma cell sensitivity to cisplatin, SOX9 was overexpressed in PC-9 PC4-knockdown cells and treated with cisplatin.